Ottmar Janssen

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 9

Top Venues

Cells

Oncoimmunology

Cellular and molecular life sciences : CMLS

Cancers

University Hospital Schleswig-Holstein

University of Ulm (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital Schleswig-Holstein

Germany

Head of Molecular Immunology :: Institute for Immunology

Christian-Albrechts-Universität zu Kiel

Germany

University Professor for Molecular Immunology :: Medical Faculty

University Hospital Schleswig-Holstein

Germany

Group Leader Biochemistry and Molecular Immunology :: Institute for Immunology

Paul-Ehrlich-Institut

Germany

Group Leader Biochemistry and Signal Transduction :: Immunology

Dana Farber Cancer Institute

United States

Research Associate :: Tumor Immunology

Dana Farber Cancer Institute

United States

Postdoctoral Fellow :: Tumor Immunology

Ruprecht Karls Universität Heidelberg

Germany

Postdoctoral Fellow :: Institute for Immunology

University of Ulm

Germany

staff scientist (PhD student) :: Medical Microbiology and Immunlogy

Education History

University of Ulm

Germany

PHD :: Medical Faculty

Publications

Lara Ploeger, Patrick Kaleja, Andreas Tholey, Marcus Lettau, Ottmar Janssen
Analysis of Cytotoxic Granules and Constitutively Produced Extracellular Vesicles from Large Granular Lymphocytic Leukemia Cell Lines. Cells 13 (16) (2024)
Lara Ploeger, Patrick Kaleja, Andreas Tholey, Marcus Lettau, Ottmar Janssen
Analysis of Cytotoxic Granules and Constitutively Produced Extracellular Vesicles from Large Granular Lymphocytic Leukemia Cell Lines. Cells 13 (16) (2024)
Lara Ploeger, Patrick Kaleja, Andreas Tholey, Marcus Lettau, Ottmar Janssen
Analysis of Cytotoxic Granules and Constitutively Produced Extracellular Vesicles from Large Granular Lymphocytic Leukemia Cell Lines. Cells 13 (16) (2024)
Dana Hellmold, Carolin Kubelt, Tina Daunke, Silje Beckinger, Ottmar Janssen, Margarethe Hauck, Fabian Schütt, Rainer Adeling, Ralph Lucius, Jochen Haag, Susanne Sebens, Michael Synowitz, Janka Held-Feindt
Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells. International journal of molecular sciences 24 (10) (2023)
Birthe Bernicke, Nils Engelbogen, Katharina Klein, Jeanette Franzenburg, Christoph Borzikowsky, Christian Peters, Ottmar Janssen, Ralf Junker, Ruben Serrano, Dieter Kabelitz
Analysis of the Seasonal Fluctuation of γδ T Cells and Its Potential Relation with Vitamin D 3 . Cells 11 (9) (2022)
Guranda Chitadze, Ulrike Wehkamp, Ottmar Janssen, Monika Brüggemann, Marcus Lettau
The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells. Cancers 13 (23) (2021)
Marcus Lettau, Michelle Dietz, Sarah Vollmers, Fred Armbrust, Christian Peters, Thi Mai Dang, Guranda Chitadze, Dieter Kabelitz, Ottmar Janssen
Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4. Cellular and molecular life sciences : CMLS 77 (4) (2019)
Christian Peters, Annika Meyer, Léonce Kouakanou, Julia Feder, Tim Schricker, Marcus Lettau, Ottmar Janssen, Daniela Wesch, Dieter Kabelitz
TGF-β enhances the cytotoxic activity of Vδ2 T cells. Oncoimmunology 8 (1) (2018)
Patrik Theodor Nerdal, Christian Peters, Hans-Heinrich Oberg, Hristo Zlatev, Marcus Lettau, Elgar Susanne Quabius, Sofia Sousa, Daniel Gonnermann, Seppo Auriola, Daniel Olive, Jorma A Määttä, Ottmar Janssen, Dieter Kabelitz
Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte Populations. Journal of immunology (Baltimore, Md. : 1950) 197 (8) (2016)

Ottmar Janssen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ottmar Janssen